Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash from Operations (2021 - 2025)

Historic Cash from Operations for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$2.6 million.

  • MDxHealth's Cash from Operations rose 5663.16% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.8 million, marking a year-over-year decrease of 410.23%. This contributed to the annual value of -$24.7 million for FY2024, which is 953.27% up from last year.
  • Latest data reveals that MDxHealth reported Cash from Operations of -$2.6 million as of Q3 2025, which was up 5663.16% from -$1.9 million recorded in Q2 2025.
  • MDxHealth's 5-year Cash from Operations high stood at $24.9 million for Q2 2022, and its period low was -$17.7 million during Q2 2023.
  • Its 5-year average for Cash from Operations is -$3.5 million, with a median of -$6.1 million in 2024.
  • Examining YoY changes over the last 5 years, MDxHealth's Cash from Operations showed a top increase of 21101.63% in 2023 and a maximum decrease of 17128.84% in 2023.
  • Quarter analysis of 5 years shows MDxHealth's Cash from Operations stood at -$7.2 million in 2021, then fell by 23.46% to -$8.9 million in 2022, then rose by 29.52% to -$6.3 million in 2023, then grew by 26.93% to -$4.6 million in 2024, then skyrocketed by 42.66% to -$2.6 million in 2025.
  • Its last three reported values are -$2.6 million in Q3 2025, -$1.9 million for Q2 2025, and -$4.6 million during Q1 2025.